Performance
Trailing returns
| 1 day |
| -0.53% | |||
| 1 week | +1.49% |
| |||
| 4 week | +6.26% |
| |||
| 3 month | +7.80% |
| |||
| YTD | +17.93% |
| |||
| 1 year | +28.77% |
| |||
| 3 years* | +16.06% |
| |||
| 5 years* | +7.49% |
| |||
| *annualized | |||||
| Best 3 month return | +28.60% | |
| Worst 3 month return | -36.66% |
Morningstar statistics
Morningstar category: Mid-Cap Blend
| Return | Risk | Rating | |
| 3 years | Above Average | Average |
 
|
| 5 years | Above Average | Average |
|
| 10 years | Above Average | Average |
|
| Overall | Above Average | Average |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 3.00B | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.50% | |
| Management fee | - | |
| Fund family | Dreyfus |
Asset allocation
| Cash | -0.23% | |
| Stocks | 100.12% | |
| Bonds | 0.00% | |
| Other | 0.11% |
Purchase information
| Initial | US$2,500 | |
| Additional | US$100 | |
| IRA Initial | US$750 | |
| AIP Initial | US$2,500 | |
| AIP Additional | US$100 |
34.43+0.33(0.97%)
May 17, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks to match the performance of the Standard & Poor's� MidCap 400 Index. To pursue its goal, the fund generally is fully invested in stocks included in the S&P� MidCap 400 Index and in futures whose performance is tied to the index. It generally invests in all 400 stocks in the S&P� MidCap 400 Index in proportion to their weighting in the index. The S&P� MidCap 400 Index is an unmanaged index of 400 common stocks of medium-size companies. The fund is non-diversified.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
Thomas Durante (Started: Mar 31, 2000)
Richard Brown (Started: Jun 29, 2010)
Karen Wong (Started: Jun 29, 2010)
Thomas Durante (Started: Mar 31, 2000)
Richard Brown (Started: Jun 29, 2010)
Karen Wong (Started: Jun 29, 2010)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 0.94 | -1.11 | 2.34 | 2.55 | |
| Beta* | 1.02 | 1.14 | 1.14 | 1.15 | |
| Mean annual return | 1.45 | 1.17 | 0.85 | 1.03 | |
| R-squared* | 81.95 | 92.79 | 92.29 | 89.62 | |
| Standard deviation | 11.48 | 17.85 | 22.46 | 17.79 | |
| Sharpe ratio | 1.51 | 0.78 | 0.44 | 0.60 | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Regeneron Pharmaceuticals, Inc. (REGN) | 1.00% | |
| Kansas City Southern, Inc. (KSU) | 0.91% | |
| Vertex Pharmaceuticals (VRTX) | 0.89% | |
| Ametek, Inc. (AME) | 0.79% | |
| Equinix, Inc. (EQIX) | 0.78% | |
| HollyFrontier Corp (HFC) | 0.78% | |
| Church & Dwight Company, Inc. (CHD) | 0.67% | |
| Realty Income Corporation (O) | 0.66% | |
| Macerich Company (MAC) | 0.65% | |
| Henry Schein, Inc. (HSIC) | 0.60% |